Alkermes plc

NASDAQ:ALKS   2:47:59 PM EDT
15.87
-0.52 (-3.17%)
Regulatory, Equity Financing / Related

Alkermes PLC Says Nasdaq Has Temporarily Halted Trading Of Co's Ordinary Shares

Published: 10/09/2020 11:11 GMT
Alkermes Plc (ALKS) - Alkermes Plc - Nasdaq Has Temporarily Halted Trading of Co's Ordinary Shares.
Alkermes Plc - FDA Advisory Committee to Review New Drug Application for Alks 3831 for Treatment of Adults With Schizophrenia Or Bipolar I Disorder.
Alkermes Plc - Prescription Drug User Fee Act (pdufa) Target Action Date for Alks 3831 NDA is Nov.
15, 2020.